Cyntegrity | Data Science for Clinical Trials
Follow Us on LinkedIn

AI in Clinical Trials Leadership Roundtable - USA 2026

Following the successful Frankfurt Leadership Roundtable and previous Summits, Cyntegrity and Microsoft are preparing the next in-person roundtable in the United States for Q4 2026. Dates, location, and speakers will be announced soon. Stay tuned for updates.

Thank you for registering your interest. You are now on our priority list and will be the first to hear when the next roundtable is announced.

What You Missed (and What's Next)

At our last roundtable, senior pharma leaders explored how responsible AI can drive trust, reproducibility, and Critical-to-Quality risk libraries, while also shaping operational intelligence for tomorrow’s trials. The day closed with a high-energy executive panel and a skyline networking reception, proving that collaboration sparks real progress when the right minds come together.

AI Governance

Understand how organizations are establishing controlled, reviewable, and accountable AI -supported workflows within clinical trial operations.

Inspection Readiness

Explore how sponsors and CROs are preparing for increasing scrutiny around AI oversight, documentation and computerized systems governance.

Operational Adoption

Learn how leaders are balancing innovation, risk management, qualified personnel expectations, and scalable implementation across teams.

AI Futurescape

Interested in Future Events?

Although the roundtable has passed, we’d love to connect with leaders eager to shape the future of clinical trials with Responsible AI. Register if you're interested in future events.

"Leaders who build inspection-ready trials don't gamble on quality - they engineer it."

Artem Andrianov, PhD · CEO – Cyntegrity • AI-Augmented RBQM

Artem Andrianov, PhD

CEO & Founder
Cyntegrity
Aurelie Dequelson, Head of Risk Surveillance at Novartis

Aurelie Bertin

Head of Risk Surveillance
Novartis
Robert King – Executive Director, Business Segment Lead: FSP Regional Hub Leadership at Thermo Fisher Scientific

Robert King

Business Segment Lead, FSP Hubs
Thermo Fisher Scientific
Ida Holme, MD - Head of RBQM at Novo Nordisk

Ida Holme, MD

Head of RBQM
Novo Nordisk
Dr Beat Widler, Managing Partner at Widler & Schiemann AG

Beat Widler, PhD

Managing Partner
Widler & Schiemann AG
Dr Anke Diehl, Chief Transformation Officer, University Medicine Essen

Dr Anke Diehl

Chief Transformation Officer
University Medicine Essen
Johann Proeve, PhD at Cyntegrity

Johann Proeve, PhD

Chief Scientific Officer
Cyntegrity
Shehnaz Vakharia, MRQA - VP, APAC at ADAMAS

Shehnaz Vakharia, MRQA

VP, APAC
ADAMAS Consulting
Patrick Lamplé - Healthcare and Life Sciences Industry Advisor at Microsoft

Patrick Lample

HC & LS Industry Advisor
Microsoft

Designed For

VPs / Directors in Clinical Ops, Quality, Digital Transformation & Data Science who plan to embed Responsible AI in study oversight within 12 months.

PORTFOLIO-GRADE RBQM

© 2026 Cyntegrity - All Rights Reserved

Cyntegrity | Data Science for Clinical Trials